ClinicalTrials.Veeva

Menu

Renal Fractional Flow Reserve in Renal Artery Stenting (PREFFER)

N

National Institute of Cardiology, Warsaw, Poland

Status

Completed

Conditions

Hypertension
Renal Artery Stenosis

Treatments

Procedure: Renal artery stenting

Study type

Interventional

Funder types

Other

Identifiers

NCT01128933
2P05B02530

Details and patient eligibility

About

The purpose of the study is to determine potential utility of renal fractional flow reserve in prognosis predicting after renal stent implantation.

Enrollment

45 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least moderate (60% or more) renal artery stenosis with atheromatic appearance in angiography
  • Hypertension defined according to WHO criteria
  • Age 18-75 years
  • Signed informed consent obtained

Exclusion criteria

  • Bilateral renal artery stenosis or significant renal artery stenosis in solitary kidney
  • Contraindications to percutaneous renal angioplasty with stenting
  • Atrophy of the kidney supplied with stenosed artery
  • Other well known secondary reason for hypertension
  • Chronic heart failure NYHA II-IV
  • Significant valvular heart disease qualified for surgery
  • Persistent atrial fibrillation
  • Renal failure with GFR below 30ml/min

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

45 participants in 1 patient group

Hypertensive patients
Experimental group
Description:
Hypertensive patients with at least moderate renal artery stenosis
Treatment:
Procedure: Renal artery stenting

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems